Get the Stockscreener App
225.08
0.07%
0.16
After Hours:
225.08
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cencora Inc stock is traded at $225.08, with a volume of 1.27M.
It is up +0.07% in the last 24 hours and down -6.05% over the past month.
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
See More
Previous Close:
$224.92
Open:
$225.25
24h Volume:
1.27M
Relative Volume:
0.90
Market Cap:
$44.09B
Revenue:
$283.83B
Net Income/Loss:
$1.86B
P/E Ratio:
26.39
EPS:
8.53
Net Cash Flow:
$3.83B
1W Performance:
-1.42%
1M Performance:
-6.05%
6M Performance:
-7.37%
1Y Performance:
-100.00%
1-Day Range:
$223.67
$225.46
1-Week Range:
$221.18
$227.83
52-Week Range:
$214.77
$247.66
Cencora Inc Stock (COR) Company Profile
Name
Cencora Inc
Sector
Industry
Phone
610-727-7000
Address
1 WEST FIRST AVENUE, CONSHOHOCKEN
Cencora Inc Stock (COR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Jan-31-23 | Resumed | Evercore ISI | Outperform |
| Oct-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-11-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| May-26-22 | Upgrade | Barclays | Equal Weight → Overweight |
| Apr-12-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-12-21 | Resumed | Evercore ISI | In-line |
| Feb-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-02-21 | Upgrade | Cowen | Market Perform → Outperform |
| Jan-06-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-10-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-03-20 | Initiated | Mizuho | Neutral |
| Aug-06-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-15-20 | Initiated | Barclays | Underweight |
| Jun-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-23-20 | Resumed | Credit Suisse | Outperform |
| Apr-16-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-13-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-01-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-17-20 | Upgrade | Citigroup | Neutral → Buy |
| Feb-11-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Jul-10-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-11-19 | Initiated | Guggenheim | Buy |
| Apr-10-19 | Downgrade | BofA/Merrill | Buy → Underperform |
| Apr-10-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-11-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-10-18 | Downgrade | Jefferies | Buy → Hold |
| Oct-26-18 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-20-18 | Initiated | Berenberg | Buy |
| Jul-17-18 | Resumed | Stifel | Hold |
| Apr-09-18 | Initiated | MoffettNathanson | Buy |
| Mar-12-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| Mar-12-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-25-17 | Initiated | JP Morgan | Neutral |
| Sep-22-17 | Initiated | William Blair | Outperform |
View All
Cencora Inc Stock (COR) Latest News
Cencora Inc. stock rises Monday, still underperforms market - MarketWatch
Cencora, Inc. (NYSE:COR) Shares Bought by Mackenzie Financial Corp - MarketBeat
McKesson, Cencora and Cardinal Health Circle Florida Cancer Specialists - MSN
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now - MSN
Legal & General Group Plc Has $422.54 Million Stake in Cencora, Inc. (NYSE:COR) - MarketBeat
Legal & General Group Plc Grows Position in Cencora, Inc. (NYSE:COR) - MarketBeat
The Manufacturers Life Insurance Company Purchases 18,935 Shares of Cencora, Inc. (NYSE:COR) - MarketBeat
Wall Street SWOT: Cencora stock rides healthcare wave amid market volatility - Investing.com
APG Asset Management N.V. Decreases Stock Position in Cencora, Inc. (NYSE:COR) - MarketBeat
Cencora Inc. stock rises Thursday, still underperforms market - MarketWatch
Cencora, Inc. (NYSE:COR) Shares Bought by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp - MarketBeat
AmerisourceBergen Can't Escape Workers' 401(k) Fee Suit - Law360
Why Cencora (COR) is a Top Growth Stock for the Long-Term - Yahoo Finance
Cencora, Inc. (NYSE:COR) Shares Acquired by Zurich Insurance Group Ltd FI - MarketBeat
Cencora, Inc. (NYSE:COR) Shares Sold by Pacer Advisors Inc. - MarketBeat
Kayne Anderson Rudnick Investment Management LLC Sells 16,133 Shares of Cencora, Inc. (NYSE:COR) - MarketBeat
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now - MSN
Cencora (NYSE:COR) Stock Rating Lowered by StockNews.com - MarketBeat
Del. Justices Uphold Toss Of AmerisourceBergen Syringe Suit - Law360
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now - Zacks Investment Research
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now - Yahoo Finance
Cencora Wins Again in Delaware Litigation Over Syringe Scam - Bloomberg Law
These 4 Measures Indicate That Cencora (NYSE:COR) Is Using Debt Reasonably Well - Yahoo Finance
May 2025 Options Now Available For Cencora (COR) - Nasdaq
Citi maintains Buy on Cencora shares amid cyber attack By Investing.com - Investing.com Australia
Crypto Hack Alert: How Cencora Was Forced to Pay $75M to Cybercriminals - Coinpedia Fintech News
Burgundy Asset Management Ltd. Sells 6,120 Shares of Cencora, Inc. (NYSE:COR) - MarketBeat
Cencora Pays Record $75M Ransom in Major Cyberattack - Crypto Times
BofA downgrades Cencora stock, cuts price target By Investing.com - Investing.com Canada
BofA downgrades Cencora stock, cuts price target By Investing.com - Investing.com Australia
Citi maintains Buy on Cencora shares amid cyber attack By Investing.com - Investing.com Canada
Insider Sale: Cencora Inc (COR) CEO Steven Collis Sells 21,509 S - GuruFocus.com
Cencora Inc.'s CEO Steven Collis sells $5.18 million in stock By Investing.com - Investing.com South Africa
Citi maintains Buy on Cencora shares amid cyber attack - Investing.com India
BofA downgrades Cencora stock, cuts price target - Investing.com India
Cencora Inc.'s CEO Steven Collis sells $5.18 million in stock - Investing.com Canada
Cencora Inc.'s CEO Steven Collis sells $5.18 million in stock - Investing.com
Cencora Inc.'s CEO Steven Collis sells $5.18 million in stock - Investing.com India
Cencora Inc.'s CEO Steven Collis sells $5.18 million in stock - Investing.com UK
Citi maintains Buy on Cencora shares amid cyber attack - Investing.com
Gang Got $75 Million for Cencora Hack in Largest Known Ransom - Bloomberg
ZachXBT Unearths $75M Bitcoin Theft from Cencora in Major Scam - CryptoNewsZ
Cencora (NYSE:COR) Stock Price Down 2% - MarketBeat
BofA downgrades Cencora stock, cuts price target - Investing.com
Cencora pays $75 million in Bitcoin in the largest known case of ransomware attack - Crypto Briefing
Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly - Simply Wall St
Edgestream Partners L.P. Lowers Stake in Cencora, Inc. (NYSE:COR) - MarketBeat
Cencora: Credentials To Die For, But Underlying Issues Make Case For 'Hold' Rating (COR) - Seeking Alpha
Cencora Launches Innovative Pharmacy Education Programs to Enhance Supply Chain Expertise - MyChesCo
Renaissance Technologies LLC Sells 103,400 Shares of Cencora, Inc. (NYSE:COR) - MarketBeat
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora Inc Stock (COR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.66%
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):